why choose us

First received: July 25, 2022

Clinical Trial: Cholesterol and Inflammation Lowering Via Bempedoic Acid, an ACL-inhibiting Regimen in HIV Trial (CLEAR HIV Trial)

Study Status: Completed

Recruit Status: RECRUITING

Condition: Dyslipidemias

Study Type: INTERVENTIONAL


Official Title: Cholesterol and Inflammation Lowering Via Bempedoic Acid, an ACL-inhibiting Regimen in HIV Trial (CLEAR HIV Trial)

Brief Summary: This is a randomized placebo-controlled study in treated and suppressed HIV-infected individuals aged ?40 years with either known CVD or 1 CVD risk factor to study the effect of Bempedoic acid (BA) on safety, arterial inflammation as assessed by FDG-PET/CT, lipids, inflammation, immune activation, cardiometabolic indices, and non-calcified plaque (NCP) in the coronary arteries (assessed by coronary CT angiography, CCTA).This trial will be enrolled at UCSF and UCLA.Collaborators at Massachusetts General…

Read more